BACKGROUND: It is very common to offer low molecular weight heparin (LMWH) medications to women with unexplained habitual abortion, to increase the livebirth rate. Although no benefit from LMWH has been clearly demonstrated, examination of the effects of enoxaparin on placental structure is lacking. OBJECTIVE: To assess placental structural changes in pregnancies treated with enoxaparin, compared with controls. DESIGN AND SETTING: Case control study in an obstetrics and gynecology unit of a tertiary level university hospital in Turkey. METHODS: Forty patients who had had term pregnancies and live births but also histories of habitual abortion were recruited for this study. Placentas were sampled using a systematic random sampling method. Tissue samples were obtained, embedded and sectioned for routine histological analyses. Hematoxylin and eosin staining was used. Surface area and length estimates from placental components were evaluated by using Image J. Cell proliferation and apoptosis were also assessed via immunohistochemistry. RESULTS: There were no significant differences between the groups regarding maternal age, abortion rate, birth weight or gestational age. Comparison of the enoxaparin and control groups showed that there were no significant differences in terms of surface area and ratios of placental components. We found that Bcl-2 was generally expressed at high levels in the enoxaparin group, while there was no difference in terms of Ki-67 between the groups. CONCLUSIONS: This study demonstrates that enoxaparin did not show any significant effect on the placental structure of cases that had histories of habitual abortion.
9 February 2026 in The Journal of Maternal-Fetal & Neonatal Medicine
To compare the efficacy, safety, and reproductive outcomes of hysteroscopic resection versus conventional dilation and curettage (D&C) in the management of retained products of conception (RPOC) following delivery or abortion. This retrospective cross-sectional study included 55 patients diagnosed with RPOC at a tertiary care center between January 2015 and December 2025. The surgical intervention selected for each patient was determined by clinical indications, with either hysteroscopic resection or dilation and curettage (D&C) being the preferred option. The diagnosis was confirmed by transvaginal ultrasonography and histopathological examination. A comprehensive analysis encompassing demographic characteristics, clinical manifestations, surgical outcomes, and fertility outcomes was conducted between the two groups. Hysteroscopy was performed in 28 patients (50.9%). D&C was performed in 27 patients (49.1%). The median time from pregnancy termination to intervention was significantly longer in the hysteroscopy group (28 vs. 7.5 days; p = 0.036). Residual tissue size and operative time were also significantly greater in the hysteroscopy group (p = 0.017 and p < 0.001, respectively). Although not statistically significant, time to conception was shorter in the hysteroscopy group (5 vs. 9.4 months), and the rate of pregnancy desire was significantly higher (82.1% vs. 66.7%; p = 0.021). Pregnancy was observed to be more prevalent in the D&C group during the follow-up period. However, this difference did not attain statistical significance. Hysteroscopy and dilation and curettage (D&C) have been demonstrated to be both effective and safe options for RPOC. The use of hysteroscopy, with its capacity for direct visualization and targeted removal, is supported by its efficacy in precise intrauterine assessment. The fertility outcomes observed in this cohort were comparable between the study groups.